The FDA and Oversight of Stem Cells: Implications for Parkinson’s Disease by Jeffrey H. Kordower, PhD and Patrik Brundin MD, PhD Read More Clinical ScienceJeffrey H. Kordower PhDSeptember 25, 2017Stem Cells, Clinical Trials, FDA, September 2017, one, FirstComment
